Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05255978

A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.

This is a prospective/retrospective, observational follow-up study of effects of fatty liver on chronic hepatitis B. Patients will join this study who undergo transient elastography with liver stiffness (LS) and CAP measurements or Ultrasonic examination. All recruited subjects will undergo comprehensive clinical, anthropometric and laboratory assessments at the time when transient elastography or Ultrasonic examination is performed. We plan to compare the relationship between chronic hepatitis B and non-alcoholic fatty liver disease. Patients will be divided into several groups based on the demand.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department and Institute of Infectious Disease

Wuhan, Hubei, 430030, China

Location status: Recruiting

Location contact

Meifang Han, professor

CONTACT

[email protected]

Qin Ning, professor

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age > 18 years, chronic hepatitis B patients -

Exclusion criteria

patients with chronic hepatitis C or D and human immunodeficiency virus co-infection, excessive alcohol intake (≥30 g/d for men, ≥20 g/d for women), other chronic liver diseases (e.g. primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, Wilson's disease), or on medications known to induce hepatic steatosis (including corticosteroids, methotrexate, and tamoxifen), and pregnancy.

-

Treatment and study plan

Primary outcomes

  1. disease progression

    Time frame: 3 years to 10 years

    the effect of NAFLD on CHB

Study contacts

Contact information is provided by the study sponsor or research team.

Meifang Han, Doctor

CONTACT

[email protected]

83662391 ext. 8627

Ning Qin, Doctor

CONTACT

[email protected]

83662391 ext. 8627

Sponsors and collaborators

Lead sponsor

Qin Ning

Other

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2030
First posted
Feb 25, 2022
Registry last updated
Feb 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.